Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of the effect of levothyroxine on benign thyroid nodule volume
IRCT2015091424021N1Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of levothyroxine sodium in benign thyroid nodule, sponsored by Guilan University of Medical Sciences. Primary endpoint: Change in benign thyroid nodule volume. Started Aug 2015; status: completed.
02
Drugs
levothyroxine sodium
03
Conditions
benign thyroid nodule
Beyond the preview
Go deeper on IRCT2015091424021N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015091424021N1.